NAD+ and Tirzepatide Together: Safety & Evidence

Last reviewed: June 2, 2026

Last updated: June 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Can you safely combine NAD+ supplementation with tirzepatide? The short answer is: concurrent use may be possible, but clinical evidence is sparse and individual safety depends entirely on your medical history, current medications, and provider oversight. No published studies specifically evaluate this combination.

Many patients seeking weight loss explore stacking supplements with GLP-1 receptor agonists like tirzepatide, hoping for additive metabolic benefits. Understanding the science—and what we don't yet know—helps you approach this conversation with your healthcare provider from a position of informed skepticism rather than speculative enthusiasm.

What NAD+ Does and How It Differs From Tirzepatide

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy metabolism, DNA repair, and mitochondrial function. It declines with age, and some research suggests NAD+ supplementation may support metabolic health and cellular stress resistance. However, most evidence comes from animal models or small human trials.

Tirzepatide, by contrast, is a dual GLP-1 and glucose-dependent insulinotropic peptide (GIP) receptor agonist that directly regulates appetite, insulin secretion, and glucose control. These are mechanistically distinct pathways: NAD+ works intracellularly on energy production; tirzepatide acts on hormonal appetite and metabolic regulation. They are not directly redundant, but overlap in global metabolic effects remains understudied.

Mechanism Comparison: NAD+ Pathways vs. Tirzepatide Action

Understanding how these compounds work independently helps clarify why interaction data is limited. Below is a framework comparing their primary mechanisms and metabolic targets.

Compound	Primary Mechanism	Metabolic Target	Evidence Grade
NAD+	Cellular energy and sirtuins/PARPs	Mitochondrial function, stress resistance	Preclinical to small human trials
Tirzepatide	GIP receptor agonism	Appetite, insulin, glucose control	Phase III RCTs, FDA approval
Combination	Theoretical additive metabolic boost	Unknown synergy or interference	No published clinical data
Safety profile overlap	Potential GI effects, energy shifts	Drug-supplement interactions unknown	Provider assessment required

Current Clinical Evidence on NAD+ and GLP-1 Combination Therapy

No randomized controlled trials or clinical trials have directly tested NAD+ supplementation alongside tirzepatide or other GLP-1 agonists. This is not surprising: tirzepatide is a relatively new drug, and NAD+ supplementation has niche adoption in conventional medicine. Absence of evidence is not evidence of safety.

Some observational reports and practitioner anecdotes exist in online health communities, but these lack rigorous methodology, blinded design, and standardized dosing. Case reports or patient testimonials cannot establish safety or efficacy. Any patient considering this combination should rely on provider guidance rather than peer reports.

Safety Considerations and Who Should Not Combine These Therapies

Tirzepatide can cause gastrointestinal side effects—nausea, vomiting, constipation, diarrhea—especially during dose escalation. NAD+ supplements may also affect digestion and energy levels. Combined, these effects could amplify GI symptoms or create unpredictable metabolic stress, particularly in patients with a history of pancreatitis, gastroparesis, or thyroid disease.

Patients on multiple medications, those with kidney or liver impairment, individuals with a personal or family history of medullary thyroid cancer, or anyone pregnant or breastfeeding should never consider this combination without explicit provider approval. Individual drug-supplement interactions depend on your full medication list, which only your healthcare team can evaluate comprehensively.

How PlexusDx Supports a More Personalized Approach

The Precision Peptide Genetic Test reveals predispositions in key GLP-1 and appetite-regulation pathways, including MC4R rs17782313 variants. Understanding your genetic predisposition to GLP-1 receptor sensitivity may help provide context for how effectively tirzepatide alone works for you—information that can support a more informed conversation with your provider about whether adding other supplements is necessary or beneficial.

Genetic predisposition does not predict exact medication response, nor does it tell you whether NAD+ supplementation will enhance or complicate tirzepatide's effects. However, if genetic testing reveals you have a favorable GLP-1 pathway activation pattern, tirzepatide alone may deliver the metabolic support you seek without additional supplementation. These insights should be interpreted with your qualified healthcare provider.

Rather than stacking compounds speculatively, a more evidence-based approach is to start tirzepatide as directed by your provider, assess your response over 12–16 weeks (including biomarkers like fasting glucose, weight, and metabolic markers), and only then discuss whether adjunctive NAD+ supplementation aligns with your clinical needs and risk profile.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral is $349/mo month-to-month, or from $279/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Are there any clinical trials on combining NAD+ with tirzepatide?

None. No randomized controlled trials have tested NAD+ supplementation alongside tirzepatide or any other GLP-1 receptor agonist. That is not surprising given how new tirzepatide is and how niche NAD+ supplementation remains in conventional medicine, but it leaves you without safety or efficacy data. Absence of evidence is not evidence of safety, and practitioner anecdotes online do not fill that gap.

Do NAD+ and tirzepatide work on the same pathway?

No. NAD+ is a coenzyme that acts inside the cell on energy metabolism, mitochondrial function, and pathways involving sirtuins and PARPs. Tirzepatide is a dual GLP-1 and GIP receptor agonist that acts hormonally on appetite regulation, insulin secretion, and glucose control. The article calls them mechanistically distinct rather than redundant, and says whether their broader metabolic effects add up, cancel out, or interfere is genuinely unstudied.

Could adding NAD+ make tirzepatide's stomach side effects worse?

It is a reasonable concern. Tirzepatide commonly causes nausea, vomiting, constipation, and diarrhea, particularly while a provider is escalating therapy, and NAD+ supplements can also affect digestion and energy levels. Stacking them could amplify gastrointestinal symptoms or create unpredictable metabolic stress. Patients with a history of pancreatitis, gastroparesis, or thyroid disease have the most to lose from that uncertainty.

Who should not try this combination at all?

Anyone taking multiple medications, anyone with kidney or liver impairment, anyone with a personal or family history of medullary thyroid cancer, and anyone pregnant or breastfeeding should not consider it without explicit provider approval. Drug-supplement interactions depend on your complete medication list, which only your healthcare team can evaluate as a whole. A general answer is not a substitute for a specific one here.

Is there a smarter order to try these in?

Yes — one variable at a time. The more evidence-based sequence is to start tirzepatide under provider direction, assess your response over roughly 12 to 16 weeks using weight, fasting glucose, and other metabolic markers, and only then discuss whether adjunctive NAD+ adds anything for your situation. Stacking compounds simultaneously makes it impossible to attribute either a benefit or a side effect to a cause.

Related Reading

• Tirzepatide For Weight Loss 2
• Tirzepatide Vs Semaglutide For Weight Loss
• Tirzepatide For Weight Loss
• Tirzepatide Weight Loss

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.